Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond

Overview of attention for article published in Frontiers in Pharmacology, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 24,232 followers.

RT @ShimaghavimiMD: @ibdtweets @Dana_Lukin @GhadyMoafa @GiJournal @AmJGastro @8pm It depends on the medications also https://t.co/6S4NOFe9…

11 Jun 2021

Reply Repost Favourite

RT @ShimaghavimiMD: @ibdtweets @Dana_Lukin @GhadyMoafa @GiJournal @AmJGastro @8pm It depends on the medications also https://t.co/6S4NOFe9…

10 Jun 2021

Reply Repost Favourite

@ibdtweets @Dana_Lukin @GhadyMoafa @GiJournal @AmJGastro @8pm It depends on the medications also https://t.co/6S4NOFe9cP

10 Jun 2021

Reply Repost Favourite

New Research: Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond https://t.co/czqN0Ltk6k #pharmacology

16 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.